Environmental pollutants and type 2 diabetes: A review of mechanisms that can disrupt beta cell function

Diabetologia

Volumn 54, Issue 6, 2011, Pages 1273-1290

  Hectors, T L M ^a   Vanparys, C ^a   Van Der Ven, K ^a   Martens, G A ^b   Jorens, P G ^c   Van Gaal, L F ^c   Covaci, A ^a   De Coen, W ^a   Blust, R ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Diabetes mellitus type 2; Endocrine disruptors; Environmental pollutants; Insulin secreting cells; Review

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 4,4' ISOPROPYLIDENEDIPHENOL; ARSENIC; CADMIUM; DIMETHOATE; DIMPYLATE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HEAVY METAL; INSULIN; MALATHION; MERCURY; NONYLPHENOL; ORGANOPHOSPHORUS COMPOUND; POLYCHLORINATED BIPHENYL; UNCLASSIFIED DRUG; XENOESTROGEN;

CELL DAMAGE; CONCENTRATION (PARAMETERS); DISEASE ASSOCIATION; DISEASE COURSE; ENVIRONMENTAL EXPOSURE; GENETIC PREDISPOSITION; GLUCOSE METABOLISM; HUMAN; INSULIN RELEASE; LIFESTYLE; MOLECULAR EPIDEMIOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; POLLUTANT; POLLUTION MONITORING; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; DRUG EFFECT; METABOLISM; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; ENVIRONMENTAL POLLUTANTS; ESTROGENS; HUMANS; INSULIN; INSULIN-SECRETING CELLS; METALS, HEAVY; ORGANOPHOSPHORUS COMPOUNDS; RISK FACTORS;

EID: 80052538342     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2109-5     Document Type: Review

References (110)

1. Zimmet P, Alberti KGMM, Shaw J (2001) Global and societal implications of the diabetes epidemic. Nature 414:782-787 (Pubitemid 34000780)
2. Bhatnagar A (2009) Could dirty air cause diabetes? Circulation 119:492-494
3. Grün F, Blumberg B (2009) Endocrine disrupters as obesogens. Mol Cell Endocrinol 304:19-29
4. Longnecker MP, Daniels JL (2001) Environmental contaminants as etiologic factors for diabetes. Environ Health Perspect 109 (Suppl 6):871-876 (Pubitemid 34055926)
5. Alonso-Magdalena P, Ropero AB, Soriano S, Quesada I, Nadal A (2010) BisphenolA: a newdiabetogenic factor.Hormones 9:118-126
6. Carpenter DO (2008) Environmental contaminants as risk factors for developing diabetes. Rev Environ Health 23:59-74
7. Lin Y, Sun Z (2010) Current views on type 2 diabetes. J Endocrinol 204:1-11
8. Kahn SE (2003) The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes. Diabetologia 46:3-19
9. Muoio DM, Newgard CB (2008) Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat Rev 9:193-205 (Pubitemid 351301824)
10. Rutter GA (2001) Nutrient-secretion coupling in the pancreatic islet β-cell: recent advances. Mol Aspects Med 22:247-284
11. Henquin JC (2000) Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes 49:1751-1760
12. Jones PM, Persaud SJ (1998) Protein kinases, protein phosphorylation and the regulation of insulin secretion from pancreatic β- cells. Endocr Rev 19:429-461 (Pubitemid 29116376)
13. Schuit FC, Kiekens R, Pipeleers DG (1991) Measuring the balance between insulin synthesis and insulin release. Biochem Biophys Res Commun 178:1182-1187
14. Martens GA, Pipeleers D (2009) Glucose, regulator of survival and phenotype of pancreatic beta cells. Vitam Horm 80:507-539
15. Bouwens L, Rooman I (2005) Regulation of pancreatic beta-cell mass. Physiol Rev 85:1255-1270 (Pubitemid 41362270)
16. Henriksen GL, Ketchum NS, Michalek JE, Swaby JA (1997) Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8:252-258 (Pubitemid 27183689)
17. Pesatori AC, Zocchetti C, Guercilena S, Consonni D, Turrini D, Bertazzi PA (1998) Dioxin exposure and non-malignant health effects: a mortality study. Occup Environ Med 55:126-131 (Pubitemid 28179991)
18. Cranmer M, Louie S, Kennedy RH, Hern PA, Fonseca VA (2000) Exposure to 2,3,7,8-tetranchlorodibenzo-p-dioxin (TCDD) is associated with hyperinsulinemia and insulin resistance. Toxicol Sci 56:431-436 (Pubitemid 30497514)
19. Vena J, Boffetta P, Becher H et al (1998) Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect 106(Suppl 2):645-653 (Pubitemid 28256772)
20. Philibert A, Schwartz H, Mergler D (2009) An exploratory study of diabetes in a first nation community with respect to serum concentrations of p,p′-DDE and PCBs and fish consumption. Int J Environ Res Public Health 6:3179-3189
21. Krämer U, Herder C, Sugiri D et al (2010) Traffic-related air pollution and incident type 2 diabetes: results from the SALIA cohort study. Environ Health Perspect 118:1273-1279
22. Uemura H, Arisawa K, Hiyoshi M et al (2008) Associations of environmental exposure to dioxins with prevalent diabetes among general inhabitants in Japan. Environ Res 108:63-68
23. Ukropec J, Radikova Z, HuckovaMet al (2010)High prevalence of prediabetes and diabetes in a population exposed to high levels of an organochlorine cocktail. Diabetologia 53:899-906
24. Glynn AW, Granath F, Aune M et al (2003) Organochlorines in Swedish women: determinants of serum concentrations. Environ Health Perspect 111:349-355 (Pubitemid 36395203)
25. Rignell-Hydbom A, Lidfeldt J, Kiviranta H et al (2009) Exposure to p,p′-DDE: a risk factor for type 2 diabetes. PLoS ONE 4:e7503
26. Rylander L, Rignell-Hydbom A, Hagmar L (2005) A crosssectional study of the association between persistent organochlorine pollutants and diabetes. Environ Health 4:28
27. Wang S-L, Tsai P-C, Yang C-Y, Guo YL (2008) Increased risk of diabetes and polychlorinated biphenyls and dioxins: a 24-year follow-up study of the Yucheng cohort. Diab Care 31:1574-1579
28. Codru N, Schymura MJ, Negoita S, The Akwesasne Task Force on the Environment, Rej R, Carpenter DO (2007) Diabetes in relation to serum levels of polychlorinated biphenyls and chlorinated pesticides in adult native Americans. Environ Health Perspect 115:1442-1447 (Pubitemid 47618086)
29. Cox S, Niskar AS, Narayan KMV, Marcus M (2007) Prevalence of self-reported diabetes and exposure to organochlorine pesticides among Mexican Americans: Hispanic Health and Nutrition Examination Survey, 1982-1984. Environ Health Perspect 115:1747-1752
30. Everett CJ, Frithsen IL, Diaz VA, Koopman RJ, Simpson WM Jr, Mainous AG 3rd (2007) Association of a polychlorinated dibenzo-p-dioxin, a polychlorinated biphenyl, and DDT with diabetes in the 1999-2002 National Health and Nutrition Examination Survey. Environ Res 103:413-418 (Pubitemid 46217208)
31. Lang IA, Galloway TS, Scarlett A et al (2008) Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 300:1303-1310
32. Lee D-H, Lee I-K, Song K et al (2006) A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey 1999-2002. Diab Care 29:1638-1644 (Pubitemid 44127593)
33. Lee D-H, Lee I-K, Steffes M, Jacobs DR Jr (2007) Extended analysis of the association between serum concentrations of persistent organic pollutants and diabetes. Diab Care 30:1596-1598 (Pubitemid 46871181)
34. Lee D-H, Steffes MW, Sjödin A, Jones RS, Needham LL, Jacobs DR Jr (2010) Low dose of some persistent organic pollutants predicts type 2 diabetes: a nested case-control study. Environ Health Perspect 118:1235-1242
35. Lim J-S, Lee D-H, Jacobs DR Jr (2008) Association of brominated flame retardants with diabetes and metabolic syndrome in the U.S. population 2003-2004. Diab Care 31:1802-1807
36. Montgomery MP, Kamel F, Saldana TM, Alavanja MCR, Sandler DP (2008) Incident diabetes and pesticide exposure among licensed pesticide applicators: agricultural health study, 1993-2003. Am J Epidemiol 167:1235-1246 (Pubitemid 351670637)
37. Schwartz GG, Il'yasova D, Ivanova A (2003) Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diab Care 26:468-470 (Pubitemid 36929075)
38. Turyk M, Anderson HA, Knobeloch L, Imm P, Persky VW (2009) Prevalence of diabetes and body burdens of polychlorinated biphenyls, polybrominated diphenyl ethers, and p,p′- diphenyldichloroethene in Great Lakes sport fish consumers. Chemosphere 75:674-679
39. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Thomas AB, Guallar E (2006) Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiologic evidence. Environ Health Perspect 114:641-648
40. Heldring N, Pike A, Andersson S et al (2007) Estrogen receptors: how do they signal and what are their targets. Physiol Rev 87:905-931 (Pubitemid 47084672)
41. Chen J-Q, Brown TR, Russo J (2009) Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors. Biochim Biophys Acta 1793:1128-1143
42. Nadal A, Alonso-Magdalena P, Soriano S, Quesada I, Ropero AB (2009) The pancreatic beta-cell as a target of estrogens and xenoestrogens: implications for blood glucose homeostasis and diabetes. Mol Cell Endocrinol 304:63-68
43. Alonso-Magdalena P, Ropero AB, Carrera MP et al (2008) Pancreatic insulin content regulation by the estrogen receptor ERα. PLoS ONE 3:e2069
44. Nadal A, Alonso-Magdalena P, Soriano S, Ropero AB, Quesada I (2009) The role of oestrogens in the adaptation of islets to insulin resistance. J Physiol 587:5031-5037
45. LeMayMC, Chu K,HuMet al (2006) Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc Natl Acad Sci USA 103:9232-9237
46. Nadal A, Rovira JM, Laribi O et al (1998) Rapid insulinotropic effect of 17β-estradiol via a plasma membrane receptor. FASEB J 12:1341-1348 (Pubitemid 28475575)
47. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A (2006) The estrogenic effect of bisphenol A disrupts pancreatic β-cell function in vivo and induces insulin resistance. Environ Health Perspect 114:106-112 (Pubitemid 43056876)
48. Quesada I, Fuentes E, Viso-León C, Soria B, Ripoll C, Nadal A (2002) Low doses of the endocrine disrupter bisphenol-A and the native hormone 17β-estradiol rapidly activate transcription factor CREB. FASEB J 16:1671-1673
49. Nadal A, Ropero AB, Fuentes E, Soria B, Ripoll C (2004) Estrogen and xenoestrogen actions on endocrine pancreas: from ion channel modulation to activation of nuclear function. Steroids 69:531-536 (Pubitemid 39013483)
50. ATP channel activity by 17β-estradiol in pancreatic β-cells involves the estrogen receptor β and the atrial natriuretic peptide receptor. Mol Endocrinol 23:1973-1982
51. Nadal A, Ropero AB, Laribi O, Maillet M, Fuentes E, Soria B (2000) Nongenomic actions of estrogens and xenoestrogens by binding at a plasma membrane receptor unrelated to estrogen receptor α and estrogen receptor β. Proc Natl Acad Sci USA 97:11603-11608
52. Ackermann S, Hiller S, Osswald H, Losle M, Grenz A, Hambrock A (2009) 17β-Estradiol modulates apoptosis in pancreatic β-cells by specific involvement of the sulfonylurea receptor (SUR) isoform SUR1. J Biol Chem 284:4905-4913
53. Mårtensson UEA, Salehi SA, Windahl S et al (2009) Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice. Endocrinology 150:687-698
54. Wetherill YB, Akingbemi BT, Kanno J et al (2007) In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24:178-198 (Pubitemid 47385095)
55. Richter CA, Birnbaum LS, Farabollini F et al (2007) In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24:199-224 (Pubitemid 47385096)
56. European Commission (2007) Commission Staff Working Document on the implementation of the "Community Strategy for Endocrine Disrupters"-a range of substances suspected of interfering with the hormone systems of humans and wildlife (COM(1999) 706), (COM (2001) 262) and (SEC (2004) 1372). SEC(2007) 1635. Commission of the European Communities, Brussels. Available from http://ec.europa.eu/environment/endocrine/documents/final- report-2007.pdf. Accessed 8 February 2011
57. Welshons WV, Nagel SC, Vom Saal FS (2006) Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure. Endocrinology 147:S56-S69
58. Ghafour-Rashidi Z, Dermenaki-Farahani E, Aliahmadi A et al (2007) Protection by cAMP and cGMP phosphodiesterase inhibitors of diazinon-induced hyperglycaemia and oxidative/ nitrosative stress in rat Langerhans islets cells: molecular evidence for involvement of non-cholinergic mechanisms. Pestic Biochem Physiol 87:261-270 (Pubitemid 46188336)
59. Rahimi R, Abdollahi M (2007) A review on the mechanism involved in hyperglycaemia induced by organophosphorus pesticides. Pestic Biochem Physiol 88:115-121 (Pubitemid 46463976)
60. McKinlay R, Plant JA, Bell JNB, Voulvoulis N (2008) Endocrine disrupting pesticides: implications for risk assessment. Environ Int 34:168-183 (Pubitemid 351231873)
61. Jeong SH, Kim BY, Kang HG, Ku HK, Cho JH (2006) Effect of chlorpyrifos-methyl on steroid and thyroid hormones in rat F0- and F1-generations. Toxicology 220:189-202
62. Sahin IÇ, Onbasi K, Sahin H, Karakaya C, Ustun Y, Noyan T (2002) The prevalence of pancreatitis in organophosphate poisonings. Hum Exp Toxicol 21:175-177 (Pubitemid 34662043)
63. Roeyen G, Chapelle T, Jorens P, De Beeck BO, Ysebaert D (2008) Necrotizing pancreatitis due to poisoning with organophosphate pesticides. Acta Gastroenterol Belg 71:27-29 (Pubitemid 351613482)
64. Kamath V, Rajini PS (2007) Altered glucose homeostasis and oxidative impairment in pancreas of rats subjected to dimethoate intoxication. Toxicology 231:137-146 (Pubitemid 46283158)
65. Pournourmohammadi S, Ostad SN, Azizi E et al (2007) Induction of insulin resistance by malathion: evidence for disrupted islets cells metabolism and mitochondrial dysfunction. Pestic Biochem Physiol 88:346-352 (Pubitemid 46719373)
66. Vosough-Ghanbari S, Sayyar P, Pournourmohammadi S,AliahmadiA, Ostad SN, Abdollahi M (2007) Stimulation of insulin and glucagon synthesis in rat Langerhans islets by malathion in vitro: evidence for mitochondrial interaction and involvement of subcellular non-cholinergic mechanisms. Pestic Biochem Physiol 89:130-136 (Pubitemid 47321798)
67. Panahi P, Vosough-Ghanbari S, Pournourmohammadi S et al (2006) Stimulatory effects of malathion on the key enzymes activities of insulin secretion in Langerhans islets, glutamate dehydrogenase and glucokinase. Toxicol Mech Methods 16:161-167
68. Gilon P, Henquin J-P (2001) Mechanisms and physiological significance of the cholinergic control of pancreatic β-cell function. Endocr Rev 22:565-604 (Pubitemid 32958576)
69. Romero-Navarro G, Lopez-Aceves T, Rojas-Ochoa A, Fernandez Mejia C (2006) Effect of dichlorvos on hepatic and pancreatic glucokinase activity and gene expression, and on insulin mRNA levels. Life Sci 78:1015-1020 (Pubitemid 43112541)
70. Gowda H, Uppal RP (1983) Effect of malathion on adrenal activity, liver glycogen and blood glucose in rats. Indian J Med Res 78:847-851 (Pubitemid 14162755)
71. Stockholm Convention on persistent organic pollutants (POPs) Governments unite to step-up reduction on global DDT reliance and add nine new chemicals under international treaty. Press release, 9 May 2009. Available from: http://chm.pops.int/ Convention/Pressrelease/COP4Geneva8May2009/tabid/542/ language/en-US/Default.aspx. Accessed 11 October 2010
72. Rogan WJ, Chen A (2005) Health risks and benefits of bis(4- chlorophenyl)-1,1,1-trichloroethane (DDT). Lancet 366:763-773 (Pubitemid 41207240)
73. Darras VM (2008) Endocrine disrupting polyhalogenated organic pollutants interfere with thyroid hormone signaling in the developing brain. Cerebellum 7:26-37
74. Birnbaum LS (1995) Developmental effects of dioxins and related endocrine disrupting chemicals. Toxicol Lett 82:743-750
75. NovelliM, Piaggi S, De Tata V (2005) 2,3,7,8-Tetrachlorodibenzop- dioxin-induced impairment of glucose-stimulated insulin secretion in isolated rat pancreatic islets. Toxicol Lett 156:307-314 (Pubitemid 40292804)
76. Seefeld MD, Corbett SW, Keesey RE, Peterson RE (1984) Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol 73:311-322 (Pubitemid 14135566)
77. Enan E, Liu PCC,Matsumura F (1992) 2,3,7,8-Tetrachlorodibenzop- dioxin causes reduction of glucose transporting activities in the plasma membranes of adipose tissue and pancreas from the guinea pig. J Biol Chem 267:19785-19791
78. Enan E, Liu PCC, Matsumura F (1992) TCDD causes reduction in glucose uptake through glucose transporters on the plasma membranes of the guinea pig adipocyte. J Environ Sci Health B 27:495-510
79. Ebner K, Brewster DW, Matsumura F (1988) Effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin on serum insulin and glucose levels in the rabbit. J Environ Sci Health B 23:427-438
80. Matsumura F (1995) Mechanism of action of dioxin-type chemicals, pesticides, and other xenobiotics affecting nutritional indexes. Am J Clin Nutr 61(Suppl):695S-701S
81. Piaggi S, Novelli M, Martino L et al (2007) Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD) in the β-cell line INS-1E. Toxicol Appl Pharmacol 220:333-340 (Pubitemid 46627843)
82. Michalek JE, Akhtar FZ, Kiel JL (1999) Serum dioxin, insulin, fasting glucose, and sex hormone-binding globulin in veterans of Operation Ranch Hand. J Clin Endocrinol Metab 84:1540-1543 (Pubitemid 30644250)
83. Lajoix AD, Reggio H, Chardès T et al (2001) A neuronal isoform of nitric oxide synthase expressed in pancreatic β-cells controls insulin secretion. Diabetes 50:1311-1323 (Pubitemid 32500163)
84. Sjöholm A (1996) Nitric oxide donor SIN-1 inhibits insulin release. Am J Physiol 271:C1098-C1102
85. Fischer LJ, Zhou H-R, Wagner MA (1996) Polychlorinated biphenyls release insulin from RINm5F cells. Life Sci 59:2041-2049 (Pubitemid 26401603)
86. Fischer LJ, Wagner MA, Madhukar BV (1999) Potential involvement of calcium, CaM kinase II, and MAP kinases in PCB-stimulated insulin release from RINm5F cells. Toxicol Appl Pharmacol 159:194-203 (Pubitemid 29451127)
87. Chen YW, Yang CY, Huang CF, Hung DZ, Leung YM, Liu SH (2009) Heavy metals and islet function and diabetes development. Islets 1:169-176
88. Edwards JR, Prozialeck WC (2009) Cadmium, diabetes and chronic kidney disease. Toxicol Appl Pharmacol 238:289-293
89. Ghafghazi T, Mennear JH (1975) The inhibitory effect of cadmium on the secretory activity of the isolated perfused rat pancreas. Toxicol Appl Pharmacol 31:134-142
90. Nilsson T, Rorsman F, Berggren PO, Hellman B (1986) Accumulation of cadmium in pancreatic β-cells is similar to that of calcium in being stimulated by both glucose and high potassium. Biochim Biophys Acta 888:270-277 (Pubitemid 16001405)
91. Lei LJ, Jin TY, Zhou YF (2007) Insulin expression in rats exposed to cadmium. Biomed Environ Sci 20:295-301
92. Izquierdo-Vega JA, Soto CA, Sanchez-Peña LC, De Vizcaya- Ruiz A, Del Razo LM (2006) Diabetogenic effects and pancreatic oxidative damage in rats subchronically exposed to arsenite. Toxicol Lett 160:135-142 (Pubitemid 41578957)
93. Díaz-Villaseñor A, Burns AL, Hiriart M, Cebrián ME, Ostrosky- Wegman P (2007) Arsenic-induced alteration in the expression of genes related to type 2 diabetes mellitus. Toxicol Appl Pharmacol 225:123-133
94. MacFarlane WM, Smith SB, James RF et al (1997) The p38/ reactivating kinase mitogen-activated protein kinase cascade mediates the activation of the transcription factor insulin upstream factor 1 and insulin gene transcription by high glucose in pancreatic beta-cells. J Biol Chem 272:20936-20944 (Pubitemid 27355666)
95. Paul DS, Hernández-Zavala A, Walton FS et al (2007) Examination of the effects of arsenic on glucose homeostasis in cell culture and animal studies: development of a mouse model for arsenic-induced diabetes. Toxicol Appl Pharmacol 222:305-314 (Pubitemid 47198280)
96. Stanojevic V, Habener JF, Thomas MK (2004) Pancreas duodenum homeobox-1 (PDX-1) transcriptional activation requires interactions with p300. Endocrinology 145:2918-2928 (Pubitemid 38686241)
97. Díaz-Villaseñor A, Sánchez-Soto MC, Cebrián ME, Ostrosky- Wegman P, Hiriart M (2006) Sodium arsenite impairs insulin secretion and transcription in pancreatic beta-cells. Toxicol Appl Pharmacol 214:30-34
98. Fu J, Woods CG, Yehuda-Shnaidman E et al (2010) Low level arsenic impairs glucose-stimulated insulin secretion in pancreatic β-cells: involvement of cellular adaptive response to oxidative stress. Environ Health Perspect 118:864-870
99. Chen YW, Huang CF, Tsai KS et al (2006) Methylmercury induced pancreatic β-cell apoptosis and dysfunction. Chem Res Toxicol 19:1080-1085 (Pubitemid 44389203)
100. Chen YW, Huang CF, Tsai KS et al (2006) The role of phosphoinositide 3-kinase/Akt signaling in low-dose mercuryinduced mouse pancreatic β-cell dysfunction in vitro and in vivo. Diabetes 55:1614-1624
101. US Environmental Protection Agency, Integrated Risk Information System (IRIS). Bisphenol A (CASRN 80-05-7). Available from www.epa.gov/iris/subst/0356. htm. Accessed 14 December 2010
102. vom Saal FS, Akingbemi BT, Belcher SM et al (2007) Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24:131-138 (Pubitemid 47385099)
103. Agriculture and Consumer Protection Department of Food and Agriculture Organization of the United Nations (1998) Pesticide residues in food - 1997. Report. (FAO Plant Production and Protection Paper-145). Available from http://www.fao.org/docrep/ w8141e/w8141e0x.htm#TopOfPage. Accessed 14 December 2010
104. US Environmental Protection Agency, Integrated Risk Information System (IRIS). Malathion (CASRN 121-75-5). Available from www.epa.gov/IRIS/subst/0248. htm. Accessed 14 December 2010
105. US Environmental Protection Agency (U.S. EPA) (2010) EPA's reanalysis of key issues related to dioxin toxicity and response to nas comments (external review draft). US Environmental Protection Agency, Washington, EPA/600/R-10/038A
106. US Environmental Protection Agency, Integrated Risk Information System (IRIS). Available from http://www.epa.gov/iris/. Accessed 14 December 2010
107. Calafat AM, Kuklenyik Z, Reidy JA et al (2005) Urinary concentrations of bisphenol A and 4-nonylphenol in a human reference population. Environ Health Perspect 113:391-395 (Pubitemid 40601814)
108. WHO (2009) Inventory of IPCS and other WHO pesticide evaluations and summary of toxicological evaluations performed by the Joint Meeting of Pesticide Residues (JMPR) through 2009. WHO, Geneva. Available from www.who.int/ipcs/ publications/ jmpr/pesticide-inventory-edition10.pdf. Accessed 2 December 2010
109. Agency for Toxic Substances and Disease Registry (ATSDR) (2008) Toxicological profile for cadmium (Draft for public comment). US Department of Health and Human Services, Public Health Service, Atlanta
110. Holson JF, Stump DG, Clevidence KJ, Knapp JF, Farr CH (2000) Evaluation of the prenatal developmental toxicity of orally administered arsenic trioxide in rats. Food Chem Toxicol 38:459-466 (Pubitemid 30179736)